News Articles Tagged: Health Policy

The FDA and NMN: What You Need to Know About Supplement Regulations

Understand the current regulatory landscape for NMN supplements in the US, including the FDA's stance, its classification as a drug, and the ongoing legal challenges affecting its availability as a dietary supplement.

The Economics of Antivirals: Pricing, Access, and Remdesivir's Market Dynamics

NINGBO INNO PHARMCHEM CO.,LTD. discusses the economic aspects of antiviral medications, focusing on remdesivir's pricing, access challenges, and market dynamics in global health.

The Regulatory Landscape of Triclosan: Bans, Reviews, and Consumer Action

Understand the evolving regulations surrounding Triclosan, from FDA bans to ongoing reviews, and discover how consumer advocacy plays a vital role in chemical safety.

The Regulatory Status and Safe Use of Dimetridazole (CAS 551-92-8)

Understand the global regulatory landscape and best practices for the use of Dimetridazole (CAS 551-92-8) in various applications, from NINGBO INNO PHARMCHEM CO.,LTD.

The Economic and Societal Impact of Clozapine: Beyond Clinical Efficacy

Examining the cost-effectiveness, underuse, and societal implications of Clozapine, a critical medication for severe mental illnesses.

Tianeptine's Evolving Regulatory Status and the Impact of Unregulated Market Availability

Analyze the complex regulatory landscape of Tianeptine, from its approved status in some countries to its unregulated market presence and bans in others, highlighting the challenges for public health.

Addressing Antimicrobial Resistance: Responsible Cefquinome Sulfate Use

Delve into the challenges of antimicrobial resistance in veterinary medicine and the responsible use of antibiotics like Cefquinome Sulfate for sustainable animal health.